Atlantic Sapphire
ISIN: NO0010768500 | Ticker: ASA | LEI: 2138007BY85FI48VX666
Country: Norway
Atlantic Sapphire is pioneering Bluehouse® (land-raised) salmon farming, locally, and transforming protein production, globally. The company established its innovation center in Denmark in 2011 with a focus on developing sustainable, environmentally friendly farming methods that enable the company to produce at scale in consumer end markets.
Year founded2010
Served areaWorldwide
HeadquartersDaugstadvegen 445, 6392 Vikebukt – Norway
| Line item in (usd) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 320,959,000.00 | 311,740,000.00 | 357,551,000.00 |
| Noncurrent Assets | N/A | 261,285,000.00 | 267,833,000.00 | 308,150,000.00 |
| Property Plant And Equipment | N/A | 257,080,000.00 | 264,449,000.00 | 303,122,000.00 |
| Noncurrent Receivables | N/A | 30,000.00 | 26,000.00 | 1,343,000.00 |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | N/A | 7,000.00 | 6,000.00 | 6,000.00 |
| Longterm Deposits | N/A | 831,000.00 | 748,000.00 | 1,167,000.00 |
| Current Assets | N/A | 59,674,000.00 | 43,907,000.00 | 49,401,000.00 |
| Inventories | N/A | 2,713,000.00 | 6,590,000.00 | 4,368,000.00 |
| Trade And Other Current Receivables | N/A | 1,869,000.00 | 1,449,000.00 | 1,847,000.00 |
| Current Biological Assets | N/A | 24,610,000.00 | 16,795,000.00 | 18,690,000.00 |
| Cash and cash equivalents | 24,471,000.00 | 28,909,000.00 | 17,480,000.00 | 24,103,000.00 |
| Cash | N/A | 28,523,000.00 | 17,012,000.00 | 23,683,000.00 |
| Current Restricted Cash And Cash Equivalents | N/A | 386,000.00 | 468,000.00 | 420,000.00 |
| Other Current Assets | N/A | 1,573,000.00 | 1,593,000.00 | 393,000.00 |
| Equity And Liabilities | N/A | 320,959,000.00 | 311,740,000.00 | 357,551,000.00 |
| Equity | 208,679,000.00 | 255,459,000.00 | 239,556,000.00 | 296,382,000.00 |
| Issued Capital | N/A | 917,000.00 | 1,051,000.00 | 1,716,000.00 |
| Retained Earnings | N/A | -82,625,000.00 | -215,403,000.00 | -280,409,000.00 |
| Share Premium | N/A | 335,337,000.00 | 454,256,000.00 | 577,805,000.00 |
| Reserve Of Sharebased Payments | N/A | 2,015,000.00 | 3,741,000.00 | 4,319,000.00 |
| Liabilities | N/A | 65,500,000.00 | 72,184,000.00 | 61,169,000.00 |
| Noncurrent Liabilities | N/A | 54,247,000.00 | 52,842,000.00 | 30,505,000.00 |
| Longterm Borrowings | N/A | 51,156,000.00 | 50,000,000.00 | 28,287,000.00 |
| Current Liabilities | N/A | 11,253,000.00 | 19,342,000.00 | 30,664,000.00 |
| Trade And Other Current Payables | N/A | 10,771,000.00 | 19,018,000.00 | 11,698,000.00 |
| Line item in (usd) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 6,270,000.00 | 16,851,000.00 | 18,954,000.00 |
| Other Income | N/A | 151,000.00 | 25,542,000.00 |
| Raw Materials And Consumables Used | 18,169,000.00 | 65,607,000.00 | 70,030,000.00 |
| Employee Benefits Expense | 7,448,000.00 | 10,584,000.00 | 6,294,000.00 |
| Depreciation And Amortisation Expense | 6,745,000.00 | 15,056,000.00 | 14,217,000.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 0.00 | 34,754,000.00 | 0.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 0.00 | 34,754,000.00 | 0.00 |
| Other Expense By Nature | 11,025,000.00 | 24,723,000.00 | 16,309,000.00 |
| Profit Loss From Operating Activities | -46,595,000.00 | -132,293,000.00 | -62,259,000.00 |
| Finance Income | 889,000.00 | 3,362,000.00 | 4,907,000.00 |
| Finance Costs | 9,487,000.00 | 3,847,000.00 | 7,654,000.00 |
| Profit Loss Before Tax | -55,193,000.00 | -132,778,000.00 | -65,006,000.00 |
| Income Tax Expense Continuing Operations | 0.00 | 0.00 | 0.00 |
| Profit (loss) | -55,193,000.00 | -132,778,000.00 | -65,006,000.00 |
| Line item in (usd) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | -55,193,000.00 | -132,778,000.00 | -65,006,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -1,015,000.00 | -5,068,000.00 | -79,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 6,745,000.00 | 15,056,000.00 | 14,217,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | N/A | 0.00 | 34,754,000.00 | 0.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | N/A | -1,570,000.00 | -563,000.00 | -1,824,000.00 |
| Adjustments For Sharebased Payments | N/A | 955,000.00 | 1,726,000.00 | 578,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | N/A | 576,000.00 | -5,000.00 | -243,000.00 |
| Interest Received Classified As Operating Activities | N/A | 1,888,000.00 | 3,362,000.00 | N/A |
| Cash Flows From Used In Operating Activities | N/A | -46,959,000.00 | -71,238,000.00 | -52,904,000.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 25,000.00 | 165,000.00 | 0.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 60,881,000.00 | 58,077,000.00 | 56,442,000.00 |
| Interest Received Classified As Investing Activities | N/A | N/A | 3,362,000.00 | 618,000.00 |
| Other Inflows Outflows Of Cash Classified As Investing Activities | N/A | 5,000.00 | 1,000.00 | 0.00 |
| Cash Flows From Used In Investing Activities | N/A | -60,851,000.00 | -54,549,000.00 | -55,824,000.00 |
| Proceeds From Issuing Shares | N/A | 98,617,000.00 | 119,053,000.00 | 124,214,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 89,404,000.00 | 10,495,000.00 | 29,500,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 74,001,000.00 | 10,495,000.00 | 32,663,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | -2,000.00 | 347,000.00 | 511,000.00 |
| Interest Paid Classified As Financing Activities | N/A | 2,058,000.00 | 3,847,000.00 | 4,005,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 111,964,000.00 | 114,859,000.00 | 116,535,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 4,154,000.00 | -10,928,000.00 | 7,807,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 284,000.00 | -501,000.00 | -1,184,000.00 |
| Cash and cash equivalents | 24,471,000.00 | 28,909,000.00 | 17,480,000.00 | 24,103,000.00 |
Please note that some sums might not add up.
NO0010768500
LEI2138007BY85FI48VX666
SectorAgricultural Products & Services
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.